newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech to Implement $10-Million Share Repurchase Program

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) (PharmaCyte), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced tha